Acute worsening of dermatomyositis after initiation of PARP inhibitor therapy in two women with advanced ovarian malignancy

• Chemotherapy initiation and subsequent tumor lysis can release immunogenic antigens. • Advanced staged ovarian cancer associated with dermatomyositis. • PARP Inhibitor initiation can worsen paraneoplastic syndromes like dermatomyositis. • Signs and symptoms of dermatomyositis can be confused with...

Descripción completa

Detalles Bibliográficos
Autores principales: Graves, Stephen M., Backes, Floor J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Case Reports and Case Series
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8651899/
https://www.ncbi.nlm.nih.gov/pubmed/34926755
http://dx.doi.org/10.1016/j.gore.2021.100872

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8651899/
https://www.ncbi.nlm.nih.gov/pubmed/34926755
http://dx.doi.org/10.1016/j.gore.2021.100872

Ejemplares similares